| PERIOD ENDING | 24-Apr-09 | 23-Jan-09 | 24-Oct-08 | 25-Jul-08 | | Total Revenue | 3,829,000 | 3,494,000 | 3,570,000 | 3,706,000 | | Cost of Revenue | 932,000 | 848,000 | 883,000 | 855,000 | | | Gross Profit | 2,897,000 | 2,646,000 | 2,687,000 | 2,851,000 | | | Operating Expenses | | Research Development | 368,000 | 337,000 | 326,000 | 324,000 | | Selling General and Administrative | 970,000 | 1,601,000 | 1,112,000 | 1,469,000 | | Non Recurring | 1,103,000 | 72,000 | 284,000 | 96,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 456,000 | 636,000 | 965,000 | 962,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (356,000) | 348,000 | (200,000) |
-
| | Earnings Before Interest And Taxes | 100,000 | 984,000 | 765,000 | 962,000 | | Interest Expense | 52,000 | 52,000 | 104,000 | 9,000 | | Income Before Tax | 48,000 | 932,000 | 661,000 | 953,000 | | Income Tax Expense | (80,000) | 209,000 | 90,000 | 206,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 128,000 | 723,000 | 571,000 | 747,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 128,000 | 723,000 | 571,000 | 747,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $128,000 | $723,000 | $571,000 | $747,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
